Status:

COMPLETED

Melatonin for Prevention of Radiation Induced Oral Mucositis

Lead Sponsor:

Hams Hamed Abdelrahman

Collaborating Sponsors:

Alexandria University

Conditions:

Oral Mucositis (Ulcerative) Due to Radiation

Eligibility:

All Genders

25+ years

Phase:

PHASE2

Brief Summary

The main aim of this study was to evaluate the effectiveness of melatonin in prevention of radiation induced oral mucositis clinically and biochemically.

Detailed Description

The study was designed as randomized, controlled, clinical trial. patients who were undergoing chemoradiation were divided into two groups: Group I: was given conventional treatment. Group II: was giv...

Eligibility Criteria

Inclusion

  • Patients who are going to receive radiotherapy as a treatment of head and neck cancer either as postoperative (adjuvant) therapy or definitive therapy.
  • Patients whose radiotherapy treatment planned dose is between 60-70 Gy.
  • Patients who had received chemotherapy prior to radiotherapy or are going to receive chemotherapy in concomitant to radiotherapy.

Exclusion

  • Patients under Anticoagulants such as warfarin, heparin, or aspirin.
  • Patients under Fluvoxamine (Luvox) and Nifedipine medications.
  • Patients whose radiotherapy treatment planned dose is lower than 60 Gy.
  • Pregnant and lactating women.
  • Patients suffering from any uncontrolled systemic diseases (such as diabetes, cardiovascular, liver disorder, renal dysfunction)
  • Patients with findings of any physical or mental abnormality which would interfere with or be affected by the study procedure.

Key Trial Info

Start Date :

January 12 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2018

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT03833570

Start Date

January 12 2018

End Date

December 1 2018

Last Update

June 17 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Outpatient clinic of Department of Clinical Oncology, Faculty of Medicine, Alexandria University

Alexandria, Egypt